Conference subclinical hypercortisolism 27.3.98

Recent  Advances  on Subclinical  Hypercortisolism
Guido Zavatta, MD, Guido Di Dalmazi, MD*

Endocrinol Metab Clin N Am – 2018

Main Questions:

What is the definition of Subclinical Hypercortisolism(SH)?

How much is the prevalence of SH?

What about biochemical diagnostic tools and their cut offs?

How to distinguish between different types of adrenal masses and their functional status with radiologic diagnostic tools?

How is the outcome in SH patients?

the medical, conservative, and or  surgical treatment are recommended?

SH is a pathologic condition defined as biochemical evidence of hypercortisolism in patients without typical  signs or symptoms of Cushing syndrome.

Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors

Martin Fassnacht1,2, Wiebke Arlt3,4, Irina Bancos3,4,5, Henning Dralle6,John Newell-Price7,8, Anju Sahdev9, Antoine Tabarin10, Massimo Terzolo11, Stylianos Tsagarakis12  and Olaf M Dekkers13,14

European Journal of Endocrinology(2016)  175, G1–G34